358 related articles for article (PubMed ID: 23214266)
21. In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates.
Prammananan T; Chaiprasert A; Leechawengwongs M
Int J Antimicrob Agents; 2009 Feb; 33(2):190-1. PubMed ID: 18945598
[No Abstract] [Full Text] [Related]
22. Identification of Streptomyces sp. KH29, which produces an antibiotic substance processing an inhibitory activity against multidrug-resistant Acinetobacter baumannii.
Lee KH; Kim KW; Rhee KH
J Microbiol Biotechnol; 2010 Dec; 20(12):1672-6. PubMed ID: 21193822
[TBL] [Abstract][Full Text] [Related]
23. Isolation, purification and partial characterization of antibacterial activities produced by a newly isolated Streptomyces sp. US24 strain.
Mellouli L; Ben Ameur-Mehdi R; Sioud S; Salem M; Bejar S
Res Microbiol; 2003 Jun; 154(5):345-52. PubMed ID: 12837510
[TBL] [Abstract][Full Text] [Related]
24. Isolation and structure determination of streptochlorin, an antiproliferative agent from a marine-derived Streptomyces sp. 04DH110.
Shin HJ; Jeong HS; Lee HS; Park SK; Kim HM; Kwon HJ
J Microbiol Biotechnol; 2007 Aug; 17(8):1403-6. PubMed ID: 18051613
[TBL] [Abstract][Full Text] [Related]
25. Isolation and purification of antibacterial compound from Streptomyces levis collected from soil sample of north India.
Singh V; Haque S; Khare S; Tiwari AK; Katiyar D; Banerjee B; Kumari K; Tripathi CKM
PLoS One; 2018; 13(7):e0200500. PubMed ID: 29990382
[TBL] [Abstract][Full Text] [Related]
26. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.
Richter E; Rüsch-Gerdes S; Hillemann D
Antimicrob Agents Chemother; 2007 Apr; 51(4):1534-6. PubMed ID: 17242139
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, India.
Shah AM; Shakeel-U-Rehman ; Hussain A; Mushtaq S; Rather MA; Shah A; Ahmad Z; Khan IA; Bhat KA; Hassan QP
Microb Pathog; 2017 Sep; 110():93-99. PubMed ID: 28647504
[TBL] [Abstract][Full Text] [Related]
28. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
[TBL] [Abstract][Full Text] [Related]
29. Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity.
Shetty PR; Buddana SK; Tatipamula VB; Naga YV; Ahmad J
Braz J Microbiol; 2014; 45(1):303-12. PubMed ID: 24948949
[TBL] [Abstract][Full Text] [Related]
30. AN483, a new anti-MRSA compound from Streptomyces sp.
Kwon YJ; Sohn MJ; Koshino H; Kim CJ; Kim WG
J Antibiot (Tokyo); 2016 Oct; 69(10):762-764. PubMed ID: 26758490
[No Abstract] [Full Text] [Related]
31. Identification and characterization of soil-isolated Streptomyces SJE177 producing actinomycin.
Euanorasetr J; Nilvongse A; Tantimavanich S; Nihira T; Igarashi Y; Panbangred W
Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1177-87. PubMed ID: 21073039
[TBL] [Abstract][Full Text] [Related]
32. A novel hydroxamic acid-containing antibiotic produced by a Saharan soil-living Streptomyces strain.
Yekkour A; Meklat A; Bijani C; Toumatia O; Errakhi R; Lebrihi A; Mathieu F; Zitouni A; Sabaou N
Lett Appl Microbiol; 2015 Jun; 60(6):589-96. PubMed ID: 25754683
[TBL] [Abstract][Full Text] [Related]
33. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.
Rodríguez JC; Cebrián L; López M; Ruiz M; Jiménez I; Royo G
J Antimicrob Chemother; 2004 Mar; 53(3):441-4. PubMed ID: 14963069
[TBL] [Abstract][Full Text] [Related]
34. Purification and structure elucidation of antifungal and antibacterial activities of newly isolated Streptomyces sp. strain US80.
Fourati-Ben Fguira L; Fotso S; Ben Ameur-Mehdi R; Mellouli L; Laatsch H
Res Microbiol; 2005 Apr; 156(3):341-7. PubMed ID: 15808937
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
[TBL] [Abstract][Full Text] [Related]
36. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
37. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
38. Characterization and antimicrobial activities of two Streptomyces isolates from soil in the periphery of Universiti Putra Malaysia.
Zin NZ; Tasrip NA; Desa MN; Kqueen CY; Zakaria ZA; Hamat RA; Shamsudin MN
Trop Biomed; 2011 Dec; 28(3):651-60. PubMed ID: 22433896
[TBL] [Abstract][Full Text] [Related]
39. Isolation and identification of newly isolated antagonistic Streptomyces sp. strain AP19-2 producing chromomycins.
Wu XC; Chen WF; Qian CD; Li O; Li P; Wen YP
J Microbiol; 2007 Dec; 45(6):499-504. PubMed ID: 18176531
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a novel antibacterial glycopeptide produced by Penicillium sp. M03.
Yang WH; Zhang WC; Lu XM; Jiang GS; Gao PJ
Lett Appl Microbiol; 2009 Apr; 48(4):393-7. PubMed ID: 19228293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
